Effect of gabapentin on morphine demand and pain after laparoscopic sterilization using Filshie® clips. A double blind randomised clinical trial

ISRCTN ISRCTN39209275
DOI https://doi.org/10.1186/ISRCTN39209275
Protocol serial number N/A
Sponsor Glostrup University Hospital (Denmark)
Funder Copenhagen University Hospital at Herlev (Denmark)
Submission date
07/06/2006
Registration date
05/07/2006
Last edited
25/09/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Jens Engbaek
Scientific

Department of Day Surgery
Copenhagen University Hospital at Herlev
Ringvej 75
Herlev
2730
Denmark

Study information

Primary study designInterventional
Study designRandomised double-blind placebo-controlled study
Secondary study designRandomised controlled trial
Scientific title
Study objectivesA considerable number of patients require opioids during recovery after laparoscopic sterilization. This implies nausea, dizziness and sedation and this increases the number of unplanned admissions. Gabapentin has shown excellent postoperative analgesic effects in a number of recent studies showing few side effects. This study was designed to test whether gabapentin given preoperatively can reduce the number of patients needing morphine in the recovery period.
Ethics approval(s)Approved by the Regional Ethics Committee of Copenhagen County on 15/04/2002; reference number: KA 02028s
Health condition(s) or problem(s) studiedPost operative pain after laparoscopic sterilization
InterventionFemales scheduled for laparoscopic sterilization using Filshie clips were randomised into two treatment groups (gaba group and control group).

All patients received lornoxicam 8 mg by oral administration (p.o.) for 30 min before the procedure. Patients in the gaba group received gabapentin 1,200 mg p.o. and patients in the control group received placebo capsules prior to the procedure.

All patients were anesthetized according to a protocol, using remifentanil and propofol. Postoperative analgesia was obtained with patient-controlled infusion of morphine. Pain, nausea, dizziness and sedation were scored at two and four hours after end of anesthesia.
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Gabapentin, lornoxicam, remifentanil, propofol, morphine
Primary outcome measure(s)

The primary outcome measure was number of patients requesting morphine during the first four postoperative hours

Key secondary outcome measure(s)

1. Total morphine consumption from 0-4 hours postoperatively
2. Pain at rest and during mobilization from the supine to the sitting position
2. Side effects: nausea, sedation, dizziness, and vomiting

Completion date01/11/2004

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target sample size at registration80
Key inclusion criteriaWomen presenting with laparoscopic sterilization that have also given their informed consent to participate, aged between 26 and 50 years old
Key exclusion criteria1. Allergy toward gabapentin
2. Diabetes
3. Renal disease
4. Psychiatric disorder
5. Abuse of drugs
6. Analgesic treatment within 24 hours before the study
7. Treatment with steroids
Date of first enrolment01/09/2002
Date of final enrolment01/11/2004

Locations

Countries of recruitment

  • Denmark

Study participating centre

Department of Day Surgery
Herlev
2730
Denmark

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 03/11/2006 Yes No